Cargando…
Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis
PURPOSE: This study aimed to assess the diagnostic performance of circulating tumor DNA (ctDNA) in hepatocellular carcinoma (HCC). MATERIALS AND METHODS: We enrolled all relevant studies published up to 5 January 2022. Three primary subgroups were investigated: qualitative or quantitative ctDNA anal...
Autores principales: | Li, Jia Jie, Lv, Yanqing, Ji, Huifan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637356/ https://www.ncbi.nlm.nih.gov/pubmed/36348665 http://dx.doi.org/10.7717/peerj.14303 |
Ejemplares similares
-
Different Normalization Strategies Might Cause Inconsistent Variation in Circulating microRNAs in Patients with Hepatocellular Carcinoma
por: Tang, Gusheng, et al.
Publicado: (2015) -
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
por: Menyhárt, Otília, et al.
Publicado: (2018) -
Definition and review on a category of long non-coding RNA: Atherosclerosis-associated circulating lncRNA (ASCLncRNA)
por: Lu, Shanshan, et al.
Publicado: (2020) -
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
por: Thierry, Alain R., et al.
Publicado: (2010) -
Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)